Human FTCD activation kit by CRISPRa

CAT#: GA107423

FTCD CRISPRa kit - CRISPR gene activation of human formimidoyltransferase cyclodeaminase



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
FTCD mouse monoclonal antibody, clone OTI4A7 (formerly 4A7)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


FTCD (Myc-DDK-tagged)-Human formiminotransferase cyclodeaminase (FTCD), transcript variant B
    • 10 ug

CNY 4,032.00


FTCD biotinylated mouse monoclonal detection antibody, validated for Luminex assays
    • 50 ug

CNY 2,700.00
CNY 3,790.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol FTCD
Locus ID 10841
Kit Components

GA107423G1, FTCD gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA107423G2, FTCD gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA107423G3, FTCD gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001320412, NM_006657, NM_206965
Synonyms LCHC1
Summary The protein encoded by this gene is a bifunctional enzyme that channels 1-carbon units from formiminoglutamate, a metabolite of the histidine degradation pathway, to the folate pool. Mutations in this gene are associated with glutamate formiminotransferase deficiency. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Dec 2009]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...